FDA Drug Application (203171) for TELMISARTAN by TORRENT PHARMS LTD

Back to FDA Applications sponsored by TORRENT PHARMS LTD

Application Number203171
Product Number001
FormTABLET;ORAL
Dosage20MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTELMISARTAN
Active IngredientTELMISARTAN

Active IngredientCount
List of drugs with Active Ingredient TELMISARTAN7


Back to FDA Applications sponsored by TORRENT PHARMS LTD